Rose Bengal

DRUG4 trials

Sponsors

The Oxford Dental College, Hospital and Research Center, Bangalore, India, King Saud University, University of California, San Francisco

Conditions

Acanthamoeba KeratitisBacterial KeratitisCandida Albicans InfectionCigarette SmokingFungal KeratitisOral LeukoplakiaOral Lichen PlanusPremalignant Lesion

Phase 3

Curcumin; Rose Bengal; Denture Stomatitis

King Saud UniversityCandida Albicans Infection, Cigarette Smoking

Start: 2018-07-03End: 2021-05-01Updated: 2021-04-08

Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction

CompletedNCT05110001

University of California, San FranciscoAcanthamoeba Keratitis, Fungal Keratitis

Start: 2022-08-03End: 2025-06-30Updated: 2026-01-30

Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II

Active, not recruitingNCT06271772

University of California, San FranciscoBacterial Keratitis

Start: 2024-07-01End: 2026-12-31Updated: 2025-12-18

Unknown Phase

Comparison or Rose Bengal and Toluidine Blue Staining for Lesion Detection Efficacy

CompletedNCT03031899

The Oxford Dental College, Hospital and Research Center, Bangalore, IndiaOral Leukoplakia, Oral Lichen Planus, Premalignant Lesion

Start: 2015-03-31End: 2016-03-31Updated: 2018-11-05

Related Papers

Adjunctive tacrolimus in the treatment of fungal keratitis requiring therapeutic penetrating keratoplasty.

2025-12-29

A double-masked, sham-controlled trial of rose bengal photodynamic therapy for the treatment of fungal and acanthamoeba keratitis: Rose Bengal Electromagnetic Activation with Green Light for Infection Reduction (REAGIR) study

Trials2024-08-277 citations